HealthInvest Partners AB - Q4 2021 holdings

$71 Million is the total value of HealthInvest Partners AB's 13 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was - .

 Value Shares↓ Weighting
ICPT NewINTERCEPT PHARMACEUTICALS IN$2,981,000183,000
+100.0%
4.20%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-01-18
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CHARLES RIV LABS INTL INC17Q4 201712.8%
GILEAD SCIENCES INC16Q4 202214.5%
CARDINAL HEALTH INC15Q4 202214.8%
IMMUCELL CORP15Q2 20171.7%
MCKESSON CORP14Q3 202214.6%
ANTHEM INC12Q4 201714.3%
TRIPLE-S MGMT CORP12Q4 20168.7%
LIFEPOINT HOSPITALS INC11Q2 201613.3%
SUPERNUS PHARMACEUTICALS INC10Q3 202115.5%
ANIKA THERAPEUTICS INC10Q4 201713.0%

View HealthInvest Partners AB's complete holdings history.

Latest significant ownerships (13-D/G)
HealthInvest Partners AB Q4 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
NOVAMED INCMarch 03, 2011405,8755.1%
THERAGENICS CORPFebruary 11, 20093,322,8469.9%
BIO IMAGING TECHNOLOGIES INCJanuary 09, 2009766,4255.3%
ALLION HEALTHCARE INCJuly 07, 2008887,2554.6%
SONIC INNOVATIONS INCJune 26, 20081,328,2014.9%
CANDELA CORP /DE/June 06, 2008697,1643.1%
INTEGRAMED AMERICA INCJune 02, 20082,2000.0%
AFP IMAGING CORPFebruary 04, 200827,5200.2%
OPHTHALMIC IMAGING SYSTEMSDecember 28, 2007834,4404.9%
ANGEION CORP/MNOctober 16, 2007196,0244.8%

View HealthInvest Partners AB's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-04-25
13F-HR2024-01-30
13F-HR2023-02-14
13F-HR2022-10-21
13F-HR2022-07-08
13F-HR2022-05-05
13F-HR2022-01-18
13F-HR2021-11-08
13F-HR2021-08-10
13F-HR2021-04-30

View HealthInvest Partners AB's complete filings history.

Compare quarters

Export HealthInvest Partners AB's holdings